Tuesday, 2 June 2015

Increasing acceptance Pap Smear/HPV testing would drive the European market through 2015



HPV (Human Papilloma Virus) is a virus that causes warts that are spread by sexual contact and appear on the genitals and anus of women and men. Some of the types that are sexually transmitted cannot be seen and without any noticeable symptom   These are the types of the virus that primarily infect the cervix so that women have abnormal pap smears which affects negatively the women’s health.

There is a growing global movement promoting the use of human papilloma virus (HPV) testing for the early detection of infection and PAP test especially for women above 30 years. Sometimes both the tests are performed to ascertain the symptoms. 

Studies spanning Europe and in other developed nations such as the US are predicting that worldwide there is a high level of effectiveness associated with the HPV testing which can serve as an alternative to cytology-based cervical cancer screening (the Pap smear).


Various leading vendors have made technological improvements such as, DNA probes, biochips/microarrays, immunoassays, monoclonal antibodies and IT, chromosome analysis. Growth of geriatric population is also a leading factor fuelling the growth of the market.

Researchers approach major technological breakthroughs in tumor diagnosis and various therapies and discover new specific antigens. This would unravel the mystery of the genetic basis of any disease and would revolutionize the entire industry.

There are many reports in the market which tracks the current and future market trends, growth prospects through the next five years and business profiles of major manufacturers. Recently, Research Beam has added a report titled “European Pap Smear/HPV Market 2015”. The report offers detailed insights into the key drivers and restraints, future growth prospects and business strategies of leading companies and manufacturers in Europe along with the dominant technological innovations of the Pap Smear/HPV Market. major regions profiled in this study are UK, France, Germany, Spain and Italy





No comments:

Post a Comment